We are live on ! Find out more
7IH

72 Investment Holdings Portfolio holdings

AUM $49.6M
1-Year Est. Return 684.72%
This Fund
S&P 500
This Quarter Est. Return
+46.54%
1 Year Est. Return
+684.72%
3 Year Est. Return
+1,518.31%
5 Year Est. Return
+6,127.68%
10 Year Est. Return
–
AUM
$67.1M
AUM Growth
+$44.6M
Cap. Flow
+$29M
Cap. Flow %
43.24%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
LENZ
LENZ Therapeutics
LENZ
+$21.2M
2
ANRO icon
Alto Neuroscience
ANRO
+$10.5M

Top Sells

Rank Stock Value
1
TRDA icon
Entrada Therapeutics
TRDA
+$2.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRRO icon
1
Korro Bio
KRRO
$150M
$24.9M 37.14%
276,831
– –
LENZ
2
LENZ Therapeutics
LENZ
$166M
$22.7M 33.88%
+1,017,751
New +$21.2M
ANRO icon
3
Alto Neuroscience
ANRO
$1.05B
$10.3M 15.28%
+667,778
New +$10.5M
PRAX icon
4
Praxis Precision Medicines
PRAX
$8.58B
$4.02M 6%
65,933
– –
CRBU icon
5
Caribou Biosciences
CRBU
$145M
$2.44M 3.63%
474,067
– –
TSBX
6
DELISTED
Turnstone Biologics
TSBX
$1.44M 2.15%
549,981
– –
OMGA
7
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1.29M 1.92%
352,941
– –
TRDA icon
8
Entrada Therapeutics
TRDA
$264M
– –
-172,600
Closed -$2.6M

Similar funds

SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return
VCMGDR
Vinland Capital Management Gestora de Recursos Sao Paulo, Brazil $49.7M AUM 89.81% 1-Year Est. Return
AP
AlpInvest Partners Amsterdam, Netherlands $49.7M AUM 23.93% 1-Year Est. Return
VM
Varde Management Minneapolis, Minnesota $49.3M AUM 87.64% 1-Year Est. Return
CZI
Chan Zuckerberg Initiative Redwood City, California $49.2M AUM 19.47% 1-Year Est. Return
SAMC
Spectrum Asset Management (Connecticut) Stamford, Connecticut $50M AUM 2.62% 1-Year Est. Return
PEP
Pickering Energy Partners Houston, Texas $49M AUM 78.29% 1-Year Est. Return
OM
OV Management Minneapolis, Minnesota $49M AUM 6% 1-Year Est. Return

72 Investment Holdings's Q1 2024 Portfolio in Review

As of Q1 2024, 72 Investment Holdings held 8 positions worth $67.1M, up 198% from $22.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

72 Investment Holdings deployed $29M of net new capital in Q1 2024, opening 2 new positions. Its largest new stake was LENZ Therapeutics: 1,017,751 shares worth $22.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Entrada Therapeutics, an estimated $2.6M sold.

  • 72 Investment Holdings's largest Q1 2024 buy was LENZ Therapeutics: 1,017,751 shares worth $22.7M.
  • 72 Investment Holdings fully exited Entrada Therapeutics in Q1 2024, selling an estimated $2.6M.
  • 72 Investment Holdings's ten largest holdings make up 100% of its $67.1M portfolio in Q1 2024.
  • 72 Investment Holdings opened 2 new positions and closed 1 in Q1 2024.
  • 72 Investment Holdings's portfolio value rose 198% quarter-over-quarter to $67.1M.

Based on 72 Investment Holdings's 13F filing for Q1 2024, filed 15 May 2024.